BYSI
NASD BeyondSpring Inc.$1.12 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.12, $0.02 below the day’s high of $1.14
- YTD change
- -31.29%
- vs 20-day SMA
- +61.08%
- vs 200-day SMA
- -21.21%
Price ranges
Price & Performance
-0.50 (-30.86%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 97.7% away from all-time highs of $48.49
- BYSI is down 31% since the beginning of the year
- BYSI is down 36% over the past 12 months
- BYSI is up 75% over the past 1 month
- 7% of all BYSI investors are betting against BYSI
BYSI reads very good: price sits above one of the two key moving averages, the 12-month move is -35.6%.
- Previous minute
- -$0.01
- Last hour
- +$0.01
- Last 5 days
- +49.37%
- vs 8-day SMA
- +52.47%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
BeyondSpring, Inc. engages in the development and commercialization of immuno-oncology cancer therapies. It operates through the Plinabulin Pipeline and TPD Platform segments. The Plinabulin Pipeline segment focuses on the development of cancer therapies. The TPD Platform segment engages in the development of therapeutic agents and discover chemical entities. The company was founded by Lan Huang and Lin Qing Jia in 2010 and is headquartered in Florham Park, NJ.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
